YMRC
STOK icon

Yorktown Management & Research Company’s Stoke Therapeutics STOK Stock Holding History

Yorktown Management & Research Company’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$299K Buy
+9,150
New +$294K 0.18% 221

Other funds holding STOK

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
GIM
Generali Investments Management Ljubljana, Slovenia $460M AUM 29.43% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
OCWP
Owl Creek Wealth Partners Denver, Colorado $342M AUM

Yorktown Management & Research Company's STOK Position: Q2 2026 in Review

Yorktown Management & Research Company opened a new position in Stoke Therapeutics (STOK) in Q2 2026: 9,150 shares worth $299K. The stake represents 0.18% of the portfolio and ranks #221 among its holdings.

20 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • Yorktown Management & Research Company held 9,150 shares of Stoke Therapeutics worth $299K as of Q2 2026.
  • Stoke Therapeutics was a new Yorktown Management & Research Company position in Q2 2026.
  • Stoke Therapeutics made up 0.18% of Yorktown Management & Research Company's portfolio in Q2 2026, its #221 holding.
  • 20 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on Yorktown Management & Research Company's 13F filing for Q2 2026, filed 23 Jul 2026.